Robust induction of retinal pigment epithelium cells from human induced pluripotent stem cells by inhibiting FGF/MAPK signaling
Functional decline and loss of the retinal pigment epithelium (RPE) cause retinal diseases. Clinical studies using human embryonic stem cell (hESC)- or induced pluripotent stem cell (hiPSC)-derived RPE cells have shown the safety and potential efficacy of hESC/iPSC-RPE cell transplantation. However,...
Main Authors: | Takao Kuroda, Satoshi Ando, Yuriko Takeno, Akiyoshi Kishino, Toru Kimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506119301448 |
Similar Items
-
Induced pluripotent stem cell-derived retinal pigment epithelium cell based therapy in retinal degenerative diseases
by: Tai-Chi Lin, et al.
Published: (2019) -
Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application
by: Hiroyuki Kamao, et al.
Published: (2014-02-01) -
YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway
by: Teng Li, et al.
Published: (2021-04-01) -
PLIN2 and PLIN3 in human induced pluripotent stem cell-derived retinal pigment epithelium
by: Rifa Widyaningrum, et al.
Published: (2018) -
Characterization of lincRNA expression in the human retinal pigment epithelium and differentiated induced pluripotent stem cells.
by: Elizabeth D Au, et al.
Published: (2017-01-01)